|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.880 EUR | 0.00% |
|
-2.59% | +31.97% |
| 06-29 | Sopharma AD Approves Gross Dividend for 2025 | CI |
| 06-22 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended May 2026 | CI |
| Market Cap | 1.86B 1.12B 978M 904M 830M 1.57B 108B 1.6B 10.78B 4.24B 52.63B 4.2B 4.11B 182B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.4B 1.44B 1.26B 1.17B 1.07B 2.03B 139B 2.06B 13.92B 5.47B 67.92B 5.42B 5.3B 235B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | - |
| 1 week | -2.59% | ||
| Current month | -2.59% | ||
| 1 month | -1.05% | ||
| 3 months | +6.82% | ||
| 6 months | -4.33% | ||
| Current year | +31.97% |
| 1 week | 1.88 |  | 1.9 |
| 1 month | 1.85 | | 1.94 |
| Current year | 1.41 | | 2 |
| 1 year | 1.21 | | 2 |
| 3 years | 0.89 | | 2 |
| 5 years | 0.58 | | 2 |
| 10 years | 0.41 | | 2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 29/09/20 | Buy | Chief Executive Officer | 1,000 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.59% | +41.07% | +110.50% | 1.14B | |
| +4.48% | +5.04% | -13.56% | -28.66% | 15.27B | |
| +3.27% | -0.29% | -24.07% | -33.14% | 6.93B | |
| 0.00% | -2.31% | -20.72% | -4.20% | 5.99B | |
| -0.14% | +5.88% | -8.07% | -30.02% | 3.84B | |
| 0.00% | +8.09% | +12.51% | -29.10% | 3.24B | |
| -0.11% | -2.05% | -29.06% | -48.15% | 3.15B | |
| +3.36% | +0.01% | -37.82% | -12.38% | 3.23B | |
| +1.00% | -1.68% | +94.27% | - | 2.53B | |
| +1.56% | -2.35% | -23.92% | -1.72% | 2.52B | |
| Average | +1.34% | +0.71% | -0.94% | -8.54% | 4.78B | |
| Weighted average by Cap. | +2.25% | +0.37% | -9.97% | -21.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.12B 1.04B 953M 1.8B 124B 1.84B 12.39B 4.87B 60.46B 4.83B 4.72B 209B | 2.63B 1.58B 1.38B 1.28B 1.17B 2.22B 152B 2.26B 15.24B 5.99B 74.4B 5.94B 5.81B 257B |
| Net income | 77.85M 46.75M 40.87M 37.79M 34.68M 65.64M 4.51B 66.78M 451M 177M 2.2B 176M 172M 7.6B | 134M 80.19M 70.1M 64.83M 59.49M 113M 7.73B 115M 773M 304M 3.77B 301M 295M 13.03B |
| Net Debt | 444M 267M 233M 216M 198M 375M 25.71B 381M 2.57B 1.01B 12.55B 1B 980M 43.34B | 541M 325M 284M 263M 241M 456M 31.32B 464M 3.13B 1.23B 15.3B 1.22B 1.19B 52.81B |
Employees
6,005
Sector
Drug Retailers
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | €1.850 | -1.60% | 895 |
| 15/07/26 | €1.880 | 0.00% | 7,079 |
| 14/07/26 | €1.880 | -0.79% | 2,724 |
| 13/07/26 | €1.895 | -0.26% | 5,009 |
| 10/07/26 | €1.900 | 0.00% | 439 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
